As of the latest SEC filings, Kymera Therapeutics, Inc. (KYMR) is held by 330 institutional funds. The largest fund shareholder is Fidelity Growth Company Fund (FGCKX), holding an estimated $188,592,714.45 in market value, representing 0.23% of its portfolio.
Funds holding Kymera Therapeutics, Inc. (KYMR)
Source: SEC Form N-PORT institutional portfolio disclosures
- Ticker:
- KYMR
- CIK:
- 0001815442
| Fund | Type | Manager | Weight | Market Value | Shares |
Report Date
|
Filing Date
|
|---|---|---|---|---|---|---|---|
|
FGCKX
Fidelity Growth Company Fund
|
MF | Fidelity | 0.23% | $188,592,714.45 | 2,064,507 | Feb 28, 2026 | Apr 24, 2026 |
|
VTI
VANGUARD TOTAL STOCK MARKET INDEX FUND
|
ETF | Vanguard | 0.01% | $173,423,023.11 | 2,082,159 | Mar 31, 2026 | May 28, 2026 |
|
PRJIX
T. Rowe Price New Horizons Fund, Inc.
|
MF | T. Rowe Price | 1.27% | $162,163,964.20 | 1,946,980 | Mar 31, 2026 | May 28, 2026 |
|
VGHAX
VANGUARD HEALTH CARE FUND
|
MF | Vanguard | 0.40% | $145,639,741.83 | 1,796,469 | Apr 30, 2026 | Jun 26, 2026 |
|
NAESX
VANGUARD SMALL-CAP INDEX FUND
|
ETF | Vanguard | 0.08% | $125,426,910.74 | 1,505,906 | Mar 31, 2026 | May 28, 2026 |
|
SMCWX
SMALLCAP World Fund Inc
|
MF | Independent / Boutique | 0.15% | $123,779,601.12 | 1,486,128 | Mar 31, 2026 | May 28, 2026 |
|
IWM
iShares Russell 2000 ETF
|
ETF | BlackRock / iShares | 0.16% | $116,654,474.78 | 1,400,582 | Mar 31, 2026 | May 28, 2026 |
|
PACLX
T. Rowe Price Capital Appreciation Fund
|
MF | T. Rowe Price | 0.17% | $115,723,126.00 | 1,389,400 | Mar 31, 2026 | May 28, 2026 |
|
XBI
State Street(R) SPDR(R) S&P(R) Biotech ETF
|
ETF | State Street (SPDR) | 1.16% | $86,561,631.20 | 1,039,280 | Mar 31, 2026 | May 28, 2026 |
|
PRHSX
T. Rowe Price Health Sciences Fund, Inc.
|
MF | T. Rowe Price | 0.77% | $83,487,147.43 | 1,002,367 | Mar 31, 2026 | May 28, 2026 |
|
VISGX
VANGUARD SMALL-CAP GROWTH INDEX FUND
|
ETF | Vanguard | 0.18% | $70,118,019.66 | 841,854 | Mar 31, 2026 | May 28, 2026 |
|
OTCFX
T. Rowe Price Small-Cap Stock Fund, Inc.
|
MF | T. Rowe Price | 0.82% | $65,878,308.79 | 790,951 | Mar 31, 2026 | May 28, 2026 |
|
VEMPX
VANGUARD EXTENDED MARKET INDEX FUND
|
ETF | Vanguard | 0.07% | $57,142,020.69 | 686,061 | Mar 31, 2026 | May 28, 2026 |
|
FGKFX
Fidelity Growth Company K6 Fund
|
MF | Fidelity | 0.23% | $53,107,327.35 | 581,361 | Feb 28, 2026 | Apr 24, 2026 |
|
ETAHX
Eventide Healthcare & Life Sciences Fund
|
MF | Independent / Boutique | 3.28% | $52,139,540.00 | 626,000 | Mar 31, 2026 | May 29, 2026 |
|
VEXPX
VANGUARD EXPLORER FUND
|
MF | Vanguard | 0.24% | $51,527,443.44 | 635,592 | Apr 30, 2026 | Jun 26, 2026 |
|
FCGSX
Fidelity Series Growth Company Fund
|
MF | Fidelity | 0.23% | $48,406,365.00 | 529,900 | Feb 28, 2026 | Apr 24, 2026 |
|
PRDSX
T. Rowe Price Integrated U.S. Small-Cap Growth Equity Fund
|
MF | T. Rowe Price | 0.57% | $47,231,760.04 | 567,076 | Mar 31, 2026 | May 28, 2026 |
|
FSSNX
Fidelity Small Cap Index Fund
|
MF | Fidelity | 0.14% | $45,976,094.12 | 567,116 | Apr 30, 2026 | Jun 26, 2026 |
|
PAMCX
T. Rowe Price Mid-Cap Growth Fund, Inc.
|
MF | T. Rowe Price | 0.19% | $43,727,250.00 | 525,000 | Mar 31, 2026 | May 28, 2026 |
|
IBB
iShares Biotechnology ETF
|
ETF | BlackRock / iShares | 0.53% | $43,426,156.65 | 521,385 | Mar 31, 2026 | May 28, 2026 |
|
FBIOX
Select Biotechnology Portfolio
|
MF | Fidelity | 0.79% | $42,243,985.35 | 462,441 | Feb 28, 2026 | Apr 24, 2026 |
|
FCNTX
Fidelity Contrafund
|
MF | Fidelity | 0.03% | $42,146,822.25 | 506,025 | Mar 31, 2026 | May 26, 2026 |
|
IWO
iShares Russell 2000 Growth ETF
|
ETF | BlackRock / iShares | 0.32% | $39,025,279.63 | 468,547 | Mar 31, 2026 | May 28, 2026 |
|
TRSSX
T. Rowe Price Institutional Small-Cap Stock Fund
|
MF | T. Rowe Price | 0.82% | $35,624,548.93 | 427,717 | Mar 31, 2026 | May 28, 2026 |
Advertisement (320x50)